Jagsonpal Pharmaceuticals Ltd Share Price – NSE /  BSE

Pharmaceuticals, Small Cap

Jagsonpal Pharmaceuticals has allotted 53,000 equity shares under ESOP on 11 June 2025. With this allotment, the paid up equity share capital has increased from Rs. 13,29,46,960 (constituting of 6,64,73,480 equity shares of Rs. 2/- each) to Rs. 13,30,52,960 (constituting of 6,65,26,480 equity shares of Rs. 2/- each).

Powered by Capital Market - Live News

Jagsonpal Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 6 May 2025, inter alia, have recommended the final dividend of Rs 2.5 per equity Share (i.e. 125%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

Net profit of Jagsonpal Pharmaceuticals rose 85.35% to Rs 6.58 crore in the quarter ended March 2025 as against Rs 3.55 crore during the previous quarter ended March 2024. Sales rose 34.65% to Rs 58.56 crore in the quarter ended March 2025 as against Rs 43.49 crore during the previous quarter ended March 2024.

For the full year,net profit rose 146.48% to Rs 55.36 crore in the year ended March 2025 as against Rs 22.46 crore during the previous year ended March 2024. Sales rose 28.76% to Rs 268.72 crore in the year ended March 2025 as against Rs 208.70 crore during the previous year ended March 2024.

Powered by Capital Market - Live News

Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 6 May 2025.

Powered by Capital Market - Live News